Leveljump HealthcareJMPHF EBIT per Share is $0.01 as of Sep. 2025. The stock has 2 warning signs investors should review. Among 168 Medical Diagnostics & Research companies, Leveljump Healthcare ranks worse than 595237.5% on this metric.
Leveljump Healthcare's EBIT per Share for the
three
months ended in Sep. 2025 was $0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $0.01.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Leveljump Healthcare's EBIT per Share or its related term are showing as below:
During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Leveljump Healthcare was -44.20% per year. The lowest was -44.20% per year. And the median was -44.20% per year.
JMPHF's 3-Year EBIT Growth Rate is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 12.75 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Leveljump Healthcare (OTCPK:JMPHF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Leveljump Healthcare EBIT per Share Related Terms
Leveljump Healthcare EBIT per Share Historical Data
* Premium members only.
The historical data trend for Leveljump Healthcare's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leveljump Healthcare (JMPHF) has a EBIT per Share of $0.01 as of Sep. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Leveljump Healthcare and its competitors. According to the industry distribution chart, Leveljump Healthcare ranks #999999 out of 168 companies in the Medical Diagnostics & Research industry.
Is Leveljump Healthcare's EBIT per Share too high?
Leveljump Healthcare's current EBIT per Share is $0.01. The Medical Diagnostics & Research industry median EBIT per Share is 12.75. Leveljump Healthcare's value of $0.01 is 99.9% below this industry median. Based on the distribution chart, Leveljump Healthcare ranks #999999 out of 168 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Leveljump Healthcare's EBIT per Share compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Leveljump Healthcare ranks #999999 out of 168 companies for EBIT per Share. This places Leveljump Healthcare in the lower half of its industry. The industry median EBIT per Share is 12.75. Leveljump Healthcare's value of $0.01 is 99.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Diagnostics & Research company?
The median EBIT per Share among Medical Diagnostics & Research companies is 12.75, based on 168 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leveljump Healthcare's current EBIT per Share of $0.01 is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Leveljump Healthcare and its competitors. For the Medical Diagnostics & Research industry, the median EBIT per Share is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leveljump Healthcare's current EBIT per Share is $0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leveljump Healthcare stock overvalued right now?
Leveljump Healthcare (JMPHF) has a current EBIT per Share of $0.01. The stock's GF Value™ is $0.05, compared to a current price of $0.04 — trading 14.5% below its estimated fair value. The current EBIT per Share is $0.01 and 99.9% below the Medical Diagnostics & Research industry median of 12.75. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Leveljump Healthcare (JMPHF), the current EBIT per Share is $0.01 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Leveljump Healthcare Corp is engaged in providing radiology services both by providing direct patient images and by providing Teleradiology services, which is the process of providing remote off-site reading of radiology scans such as CT, MRI, and X-ray. Its teleradiology services allow hospital staff to scan their emergency room patients, then page the company's radiologist on call, who can then remotely view, via a secured server, the images and diagnose the patient, and provide a report back to the hospital. Leveljump provides its direct-to-patient services at its Independent Healthcare Facilities (IHFs). The company operates as a single segment, with all of its core assets, intellectual property, and development work being conducted in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JMPHF has been successfully added to your 